Skip to main content

Outlook Therapeutics, Inc. (OTLK) Stock

Outlook Therapeutics, Inc. Stock Details, Movements and Public Alerts

Stock Details

Outlook Therapeutics, Inc. (OTLK), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NCM.Currently, the stock is trading at $0.34. Over the past 52 weeks, it has ranged between $0.16 and $3.39. This places the current price at 10.0% of its 52-week high and 111.2% above its 52-week low. Recent trading volume was recorded at 239,827. The 14-day Relative Strength Index (RSI) stands at 64.52, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $0.27 by 25.93%. Similarly, it is below its 200-day moving average of $0.99 by 65.66%. The MACD histogram is 0.01, indicating bullish momentum0. There is currently 1 active alert set for OTLK by users.

52-Week Range

$3.39 - $0.16

-89.97% from high · +111.18% from low

Avg Daily Volume

4,854,578

20-day average

100-day avg: 5,351,052

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-1.25

EV/EBITDA

-0.80

EPS (TTM)

-$1.38

Price to Sales

195.66

Beta

0.33

Less volatile than market

Q:How is OTLK valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is OTLK's risk profile compared to the market?
With a beta of 0.33, Outlook Therapeutics, Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability.

Performance & Growth

Profit Margin

0.00%

Operating Margin

1116.38%

EBITDA

$-58,820,440

Return on Assets

-209.04%

Q:How profitable and efficient is OTLK's business model?
0 The operating margin of 1116.38% reveals how efficiently the company runs its core business operations before interest and taxes.
Q:What are OTLK's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$40.2M

Revenue (TTM)

$205,702

Revenue/Share (TTM)

$0.01

Shares Outstanding

120.86M

Book Value/Share

-$0.60

Asset Type

EQUITY

Q:What is OTLK's market capitalization and position?
Outlook Therapeutics, Inc. has a market capitalization of $40.2M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 120.86M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does OTLK's price compare to its book value?
Outlook Therapeutics, Inc.'s book value per share is -$0.60, while the current stock price is $0.34, resulting in a price-to-book (P/B) ratio of -0.57. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$4.17

1125.49% upside potential

Analyst Recommendations

Strong Buy

0

Buy

2

Hold

1

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for OTLK?
3 analysts cover OTLK with 67% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $4.17 implies 1125.5% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on OTLK?
Current analyst recommendations:02 Buy, 1 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: May 22, 2026, 02:22 AM

Technical Indicators

RSI (14-day)

64.52

Neutral

50-Day Moving Average

$0.27

25.93% above MA-50

200-Day Moving Average

$0.99

-65.66% below MA-200

MACD Line

N/A

MACD Signal

-0.01

MACD Histogram

0.01

Bullish

Q:What does OTLK's RSI value tell investors?
The RSI (Relative Strength Index) for OTLK is currently 64.52, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret OTLK's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.00 above the signal line at -0.01, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.27) is below the 200-day MA ($0.99), forming a death cross pattern that often warns of extended weakness. Price is currently between the MAs, suggesting transition.

Indicators last updated: May 22, 2026, 07:08 AM

Active Alerts

Alert Condition
Price decreases by
Threshold
7%
Created
May 18, 2026, 04:22 PM

Stay Ahead of the Market with Outlook Therapeutics, Inc. Alerts

Set up price alerts for Outlook Therapeutics, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.